Table 3.

Summary of studies involving shoulder arthroplasty in patients 80 years or older

Study	Age (years)	Followup	Type of surgery	Type of implant	Total mortality	90-day mortality	Medical complications	Surgical complications/revisions	Outcomes
Mullett et al. [17]	84 (81–93)	4.5 (2–9) years	Primary	HA (22) TSA (7)	14%	0%	0%	1 (5%) cuff failure (revised to RSA)	Constant score 77 (adjusted) FF 88-106º
Churchill [3]	93 (91–97)	2.2 (1–4) years	Primary	TSA	16%	0%	0%	NR	FF 137° ER 50° SST 7.4
Foruria et al. [7]	82 (80–89)	5.5 (2–12) years	Primary	TSA	88%	0%	9%	Cuff failure 10% Glenoid loosening 8% Revision 7%	FF 138º ER 48º 68% excellent
Ricchetti et al. [19]	82 (80-90)	90-day mortality	Primary	TSA	0%	0%	Major 7% Minor 23%	Periprosthetic fracture 5%	NR
Mangano et al. [15]	82 (79–88)	59 (28–82) months	Primary	RSA	13%	0%	0%	Complications 10% Glenoid loosening 0%	SF-12 PCS 41 SF-12 MCS 46 ASES 78
Current study	84 (80–89)	28 (1–77) months	Revision	RSA	26%	2.6%	8%	Infection 3% Glenoid loosening 8% Reoperations 13%	FF 109° ER 31°

HA = hemiarthroplasty; TSA = total shoulder arthroplasty; RSA = reverse shoulder arthroplasty; NR = not reported; FF = forward flexion ROM; ER = external rotation ROM; SST = simple shoulder test; PCS = Physical Component Summary; MCS = Mental Component Summary; ASES = American Shoulder and Elbow Surgeons.